Zofran Class Action Lawsuit
Zofran (ondansetron) is widely used to treat nausea and vomiting during pregnancy. However, the drug is not FDA-approved for morning sickness. An increasing number of women now report birth defects after using Zofran while pregnant. Lawsuits allege the manufacturer was aware of potential fetal risks but still promoted the drug as safe and effective for expectant mothers.
If you have questions about the Zofran class action lawsuit, contact our experienced drug injury lawyers for more information at (866) 808-2424 or through our brief online form at any time.
Zofran Class Action Not Formed
Despite widespread use of the drug, a Zofran class action lawsuit has not been established. Rather, Zofran birth defect cases are filed on an individual basis. This allows each family to be represented by their own attorney, litigate the facts of their own case, and pursue compensation for the unique legal damages they experienced.
By contrast, a Zofran class action would consist of a single lawsuit filed on behalf of all claimants nationwide or within a given state. At the end of the case, any recovery would be divided among the class members according to general injury categories.
Given the complexity of the legal issues and the sensitive nature of birth defect injuries, Zofran cases can be more fairly resolved on a case-by-case basis than under the class action system.
Studies Show Increased Risk of Birth Defects
In October 2014, international researchers published findings that use of Zofran in the first trimester was associated with a statistically significant increase in cardiovascular defects and cardiac septum defects in newborns. (Reference: Danielsson, et al., Use of Ondansetron During Pregnancy and Congenital Malformations in the Infant).
Prior studies reported that Zofran use in the first trimester was associated with a two- to four-fold increase in the prevalence of atrial septal defects (ASD), ventricular septal defects (VSD), and atrioventricular septal defects (ASD). (Reference: Andersen, et al., Ondansetron Use In Early Pregnancy And The Risk Of Congenital Malformations – A Register Based Nationwide Cohort Study).
Our Zofran lawyers are also reviewing evidence of cleft lip, cleft palate, gastroschisis, craniosynostosis, and other congenital malformations.
Get a Zofran Case Review
If your family has been affected, we recommend that you consult an attorney in a timely manner to discuss your legal options. In the absence of a Zofran class action, our lawyers can evaluate your individual case at no cost and with no obligation. Call (866) 808-2424 or send a message using our online form for a free and confidential case review.